Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients

BONE MARROW TRANSPLANTATION

卷 57, 期 2, 页码 309-311

SPRINGERNATURE

-

Biophysics Oncology Hematology Immunology Transplantation